Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions

JE Fugate, AA Rabinstein - The Lancet Neurology, 2015 - thelancet.com
Almost two decades have elapsed since posterior reversible encephalopathy syndrome
(PRES) was described in an influential case series. This usually reversible clinical syndrome …

Posterior reversible encephalopathy syndrome

M Fischer, E Schmutzhard - Journal of Neurology, 2017 - Springer
The posterior reversible encephalopathy syndrome (PRES) is a neurological disorder of
(sub) acute onset characterized by varied neurological symptoms, which may include …

Posterior reversible encephalopathy syndrome

RG Geocadin - New England Journal of Medicine, 2023 - Mass Medical Soc
Posterior Reversible Encephalopathy Syndrome | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features

WS Bartynski - American Journal of Neuroradiology, 2008 - Am Soc Neuroradiology
Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic state coupled with a
unique CT or MR imaging appearance. Recognized in the setting of a number of complex …

Posterior reversible encephalopathy syndrome: clinical features and outcome

A Hinduja - Frontiers in neurology, 2020 - frontiersin.org
Background: Posterior reversible encephalopathy syndrome (PRES) is an acute neurotoxic
syndrome that is characterized by a spectrum neurological and radiological feature from …

Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings

Y Ota, AA Capizzano, T Moritani, S Naganawa… - Japanese journal of …, 2020 - Springer
Wernicke's encephalopathy (WE) is a severe and life-threatening illness resulting from
vitamin B1 (thiamine) deficiency. The prevalence of WE has been estimated from 0.4 to …

Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy

J Gust, OC Finney, D Li, HM Brakke… - Annals of …, 2019 - Wiley Online Library
Objective To test whether systemic cytokine release is associated with central nervous
system inflammatory responses and glial injury in immune effector cell‐associated …

The posterior reversible encephalopathy syndrome: what's certain, what's new?

C Roth, A Ferbert - Practical neurology, 2011 - pn.bmj.com
The posterior reversible encephalopathy syndrome is an increasingly recognised disorder.
Most patients have several symptoms; seizures are the most frequent, often multiple or …

Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features

HM Hefzy, WS Bartynski… - American Journal of …, 2009 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Hemorrhage is known to occur in posterior reversible
encephalopathy syndrome (PRES), but the characteristics have not been analyzed in detail …

Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness

EV Hobson, I Craven, SC Blank - Peritoneal Dialysis …, 2012 - journals.sagepub.com
Posterior reversible encephalopathy syndrome [PRES (also known as reversible posterior
leukoencephalopathy syndrome)] presents with rapid onset of symptoms including …